If you or someone you love has been diagnosed with hepatitis B or C, the news can feel overwhelming. But here’s the good news: today’s antiviral treatments are so effective that they can control hepatitis B for life and cure hepatitis C in as little as 8 weeks. These aren’t experimental therapies—they’re the standard of care, backed by decades of research and real-world success.

In this guide, we’ll break down:

• How hepatitis B and C differ—and why treatment approaches vary
• The latest antiviral medications that protect your liver from permanent damage
• Why hepatitis C is now considered curable for most people
• What to expect during treatment, from side effects to follow-up care

Hepatitis B vs. Hepatitis C: Key Differences

While both viruses attack the liver, they behave very differently—and so do their treatments.

Understanding these differences is crucial because it explains why hepatitis B requires ongoing management, while hepatitis C can often be eliminated entirely.

Hepatitis B: Long-Term Control to Protect Your Liver

Why Hepatitis B Can’t Be Cured—Yet

Hepatitis B is a stealthy virus. It inserts its DNA into your liver cells, creating a “reservoir” that the immune system can’t fully eliminate. While your body may clear the active infection, the viral DNA can reactivate later in life—especially if your immune system weakens due to aging, chemotherapy, or other illnesses.

This is why treatment focuses on suppressing the virus rather than curing it. The goal is to preserve the virus at undetectable levels, preventing liver damage, cirrhosis, and liver cancer.

Today’s Most Effective Hepatitis B Treatments

The gold standard for chronic hepatitis B is oral antiviral therapy. These medications work by blocking the virus’s ability to replicate, giving your liver a chance to heal. The most commonly prescribed options include:

• Tenofovir disoproxil fumarate (Viread): A powerful antiviral that’s been used for over a decade. It’s highly effective at suppressing HBV and has a low risk of resistance.
• Tenofovir alafenamide (Vemlidy): A newer formulation of tenofovir with improved safety for kidneys and bones. Studies show it’s just as effective as Viread but with fewer side effects over time (The Lancet Gastroenterology & Hepatology, 2020).
• Entecavir (Baraclude): Another first-line treatment with a strong track record. It’s particularly useful for patients who haven’t responded to other antivirals.

What to Expect During Hepatitis B Treatment

• Daily medication: You’ll take one pill per day, usually at the same time. Missing doses can allow the virus to rebound.
• Regular monitoring: Your doctor will check your viral load (HBV DNA levels) and liver function every 3-6 months to ensure the treatment is working.
• Lifelong commitment: Because the virus can reactivate, most people with chronic hepatitis B stay on antivirals indefinitely. Stopping treatment without medical supervision can lead to severe liver damage.
• Minimal side effects: Modern antivirals are well-tolerated. Some people report mild headaches or fatigue, but these usually improve after the first few weeks.

Who Needs Hepatitis B Treatment?

Not everyone with hepatitis B requires medication. Your doctor will recommend treatment if:

• Your HBV DNA levels are high (typically above 2,000 IU/mL).
• You have signs of liver damage (e.g., elevated ALT enzymes or fibrosis on imaging).
• You’re at high risk for liver cancer (e.g., family history, co-infection with hepatitis C or HIV).

Even if you don’t need treatment now, regular check-ups are essential. Hepatitis B can progress silently, so early intervention is key to preventing complications.

Hepatitis C: The Curable Infection

A Medical Breakthrough: 95% Cure Rates in 8 Weeks

Just a decade ago, hepatitis C treatment was grueling: a year of injections with interferon, which caused flu-like side effects and cured only about half of patients. Today, the story is completely different. Direct-acting antivirals (DAAs)—oral medications that target the virus directly—can cure hepatitis C in 8-12 weeks with minimal side effects. The cure rate? Over 95% for most people (CDC, 2025).

How DAAs Work

DAAs attack the hepatitis C virus at multiple stages of its lifecycle, preventing it from replicating. There are three main classes of DAAs:

• Protease inhibitors (e.g., glecaprevir, grazoprevir): Block an enzyme the virus needs to replicate.
• NS5A inhibitors (e.g., ledipasvir, velpatasvir): Interfere with a protein the virus uses to assemble new copies of itself.
• Nucleoside analog polymerase inhibitors (e.g., sofosbuvir): Mimic the building blocks of viral RNA, stopping the virus from copying its genetic material.

These medications are often combined into single-pill regimens for convenience. Some of the most commonly prescribed DAA combinations include:

• Epclusa (sofosbuvir/velpatasvir): Effective against all six genotypes of hepatitis C. Taken once daily for 12 weeks.
• Mavyret (glecaprevir/pibrentasvir): Another pan-genotypic option, with an 8-week course for most patients.
• Harvoni (ledipasvir/sofosbuvir): A well-studied combination for genotypes 1, 4, 5, and 6.

Who Should Get Treated for Hepatitis C?

The short answer: almost everyone. The American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) recommend treatment for all people with chronic hepatitis C, regardless of how long they’ve had the infection or whether they have symptoms. There’s no benefit to waiting—early treatment prevents liver damage and reduces the risk of transmitting the virus to others.

Exceptions are rare but may include:

• Children under 3 years vintage (DAAs are not yet approved for this age group).
• Pregnant women (treatment is typically deferred until after delivery).
• People with very short life expectancies due to other illnesses.

What to Expect During Hepatitis C Treatment

• Simple regimen: Most people take 1-3 pills per day for 8-12 weeks. Some newer regimens (like Mavyret) can be as short as 8 weeks for people without cirrhosis.
• Minimal side effects: DAAs are far gentler than older treatments. The most common side effects are fatigue, headache, and nausea, but these are usually mild and temporary.
• No dietary restrictions: Unlike some older medications, DAAs don’t require special diets or alcohol avoidance (though limiting alcohol is always good for liver health).
• Follow-up testing: About 12 weeks after finishing treatment, you’ll have a blood test to confirm the virus is gone. This is called a sustained virologic response (SVR), and it means you’re cured.

Life After a Hepatitis C Cure

Being cured of hepatitis C is life-changing. Here’s what it means for your health:

• Your liver can heal: Even if you had liver damage (fibrosis or cirrhosis), your liver has an amazing ability to regenerate. Studies show that curing hepatitis C can reverse fibrosis in many cases (World Journal of Virology, 2012).
• Your risk of liver cancer drops: Chronic hepatitis C is a leading cause of hepatocellular carcinoma (liver cancer). Curing the virus significantly reduces—but doesn’t eliminate—this risk. Regular screenings are still important, especially if you have cirrhosis.
• You can’t get reinfected: Unlike hepatitis B, curing hepatitis C doesn’t provide immunity. If you’re exposed to the virus again (e.g., through unprotected sex or needle sharing), you can get reinfected. Harm reduction strategies are key for people at ongoing risk.

Key Takeaways: What You Need to Know

• Hepatitis B is managed, not cured: Daily antiviral medications can suppress the virus and protect your liver for life. Treatment is often lifelong, but side effects are minimal.
• Hepatitis C is curable: Direct-acting antivirals (DAAs) can eliminate the virus in 8-12 weeks with a 95%+ success rate. Treatment is simple, with few side effects.
• Early treatment is critical: Both viruses can cause silent liver damage. The sooner you start treatment, the better your long-term outcomes.
• Regular monitoring is essential: Even after successful treatment, follow-up care helps catch any complications early.
• Vaccination matters: There’s no vaccine for hepatitis C, but the hepatitis B vaccine is highly effective. If you’re at risk for either virus, get tested and vaccinated if needed.

Frequently Asked Questions

Can I stop taking hepatitis B medication if my viral load is undetectable?

No. Hepatitis B can reactivate if you stop treatment, even if your viral load is undetectable. Always consult your doctor before making any changes to your medication regimen.

Is hepatitis C treatment covered by insurance?

Yes. In the U.S., most insurance plans—including Medicare and Medicaid—cover DAAs for hepatitis C. Some states have programs to help uninsured or underinsured patients access treatment. Your doctor or a patient navigator can help you explore your options.

Can I drink alcohol if I have hepatitis B or C?

Alcohol is toxic to the liver, and hepatitis makes your liver more vulnerable. While an occasional drink may not cause harm, it’s best to limit or avoid alcohol entirely, especially if you have liver damage. Talk to your doctor about what’s safe for you.

What’s the difference between a “cure” and “viral suppression”?

• Cure (hepatitis C): The virus is completely eliminated from your body. After treatment, you’ll test negative for hepatitis C RNA, and the virus won’t come back unless you’re reinfected.
• Viral suppression (hepatitis B): The virus is still in your body but at undetectable levels. Medication keeps it from replicating, protecting your liver from damage. If you stop treatment, the virus can reactivate.

Can I transmit hepatitis B or C if I’m on treatment?

For hepatitis B: If your viral load is undetectable, your risk of transmitting the virus is very low—but not zero. Always use protection during sex and avoid sharing razors or toothbrushes.

For hepatitis C: Once you’re cured, you can’t transmit the virus to others. However, if you’re still in treatment, you can transmit the virus until the treatment is complete and you’ve achieved SVR.

The Future of Hepatitis Treatment

While today’s treatments are already life-saving, researchers are working on even better options. For hepatitis B, scientists are exploring therapies that could eliminate the viral reservoir in liver cells, potentially leading to a functional cure. For hepatitis C, the focus is on simpler regimens (e.g., single-dose treatments) and vaccine development to prevent new infections.

One thing is clear: the era of fear around hepatitis is ending. With modern treatments, most people with hepatitis B can live long, healthy lives, and those with hepatitis C can be cured. The key is getting tested, getting treated, and staying engaged with your care.

If you haven’t been tested for hepatitis B or C, talk to your doctor—especially if you:

• Were born between 1945 and 1965 (the “baby boomer” generation, which has higher rates of hepatitis C).
• Have ever injected drugs (even once, even decades ago).
• Received a blood transfusion or organ transplant before 1992.
• Have HIV or another condition that weakens the immune system.
• Were born to a mother with hepatitis B or C.

A simple blood test could be the first step toward protecting your liver—and your future.